Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

161
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
161
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

242
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
242
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

523
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
523
Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

231
Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
231
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

153
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
153
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

91
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
91

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Publisher Correction: Ureaplasma parvum and Ureaplasma urealyticum induce distinct types of inflammation in neonates and human epithelial cell models.

Pediatric research·2025
Same author

Ureaplasma parvum and Ureaplasma urealyticum induce distinct types of inflammation in neonates and human epithelial cell models.

Pediatric research·2025
Same author

Risk Factors for Severe Pediatric Invasive Group A Streptococcal Disease.

JAMA network open·2025
Same author

The identity of implant materials governs the antimicrobial efficacy of SET-M33.

Scientific reports·2025
Same author

Immunopathological and microbial signatures of inflammatory bowel disease in partial RAG deficiency.

The Journal of experimental medicine·2025
Same author

Safety and efficacy of gene therapy for RAG1-deficient SCID.

Molecular therapy : the journal of the American Society of Gene Therapy·2025

Related Experiment Video

Updated: Nov 4, 2025

Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice
05:24

Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice

Published on: October 10, 2025

82

Perinatal Infections With Ureaplasma.

Kim Stol1, Jop Jans2, Lisa Ott de Bruin2

  • 1From the Division of Pediatric Infectious Diseases, Immunology and Rheumatology, Department of Pediatrics.

The Pediatric Infectious Disease Journal
|May 27, 2021
PubMed
Summary

Ureaplasma species are significant causes of pregnancy and newborn complications. Early detection and targeted antibiotic treatment are crucial but currently lacking for these common urogenital pathogens.

More Related Videos

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
08:50

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development

Published on: June 24, 2020

3.9K
Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
08:53

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice

Published on: December 4, 2020

6.4K

Related Experiment Videos

Last Updated: Nov 4, 2025

Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice
05:24

Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice

Published on: October 10, 2025

82
A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
08:50

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development

Published on: June 24, 2020

3.9K
Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
08:53

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice

Published on: December 4, 2020

6.4K

Area of Science:

  • Microbiology
  • Neonatal Medicine
  • Obstetrics

Background:

  • Ureaplasma species are commensals in the female urogenital tract.
  • Ascending Ureaplasma infections are linked to adverse prenatal and postnatal outcomes.
  • Neonatal Ureaplasma infections can lead to sepsis, meningitis, and bronchopulmonary dysplasia.

Purpose of the Study:

  • To review the pathophysiology of Ureaplasma infections.
  • To discuss clinical consequences and diagnostic challenges.
  • To highlight current treatment difficulties for Ureaplasma species.

Main Methods:

  • Literature review of Ureaplasma pathophysiology.
  • Analysis of clinical outcomes associated with Ureaplasma.
  • Examination of diagnostic and therapeutic strategies.

Main Results:

  • Ureaplasma species are increasingly implicated in maternal and neonatal morbidity.
  • Current diagnostic methods are insufficient for routine detection.
  • Empirical antibiotic treatments in neonates often do not target Ureaplasma.

Conclusions:

  • Ureaplasma infections pose significant risks during prenatal, perinatal, and postnatal periods.
  • Improved diagnostics are needed for timely Ureaplasma detection.
  • Development of targeted treatment protocols is essential.